Novo Nordisk A/S | Kortfristiga Skulder



Current Liabilities Ändra Datum
Bausch Health Companies USD 4.51B 137M 2024-09
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Novo Nordisk 208.36B 20.45B 2024-09
Novo Nordisk DKK 208.36B 20.45B 2024-09
Pacira USD 309.92M 3.52M 2024-12
Sanofi 30.03B 5.82B 2024-06
Supernus Pharmaceuticals USD 292.4M 889K 2024-12



Novo Nordisk A/S Kortfristiga Skulder - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.